ArticleWorld journal of clinical cases2025

Dermatitis bullosa caused by the immune checkpoint inhibitor camrelizumab: A case report.

Yuan-Jing Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.